Innes Guy Archibald

Average Profitability
<0.0001%
Insider Buys Quantity
11
Insider Buys Sum
$2.12M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Innes Guy Archibald

According to the SEC Form 4 filings, Innes Guy Archibald, being in a position of

  1. director at VolitionRx Limited,
    оver the last 12 months, has bought 200000 shares for $137,700, and sold 0 shares,
    over all time since 2015-02-11, has bought 912000 shares for $2.12M, and sold 0 shares.

The largest purchase of all time was on 2021-05-14 and amounted to 200000 shares of VolitionRx Limited for $658,000.

Biography of Innes Guy Archibald

No biography is available at this moment.

2024-08-20PurchaseVolitionRx Limited
VNRX
director
150,000
0.1651%
$0.67$100,500+2.59%
2023-11-27PurchaseVolitionRx Limited
VNRX
director
20,000
0.0247%
$0.77$15,400-3.91%
2023-11-24PurchaseVolitionRx Limited
VNRX
director
10,000
0.013%
$0.76$7,600-0.42%
2023-11-22PurchaseVolitionRx Limited
VNRX
director
20,000
0.0252%
$0.71$14,200+2.52%
2023-02-22PurchaseVolitionRx Limited
VNRX
117,000
0.1911%
$1.75$204,750-29.78%
2022-08-02PurchaseVolitionRx Limited
VNRX
75,000
0.1378%
$2.00$150,000-9.28%
2022-05-16PurchaseVolitionRx Limited
VNRX
20,000
0.0332%
$2.37$47,400-25.66%
2021-05-17PurchaseVolitionRx Limited
VNRX
director
100,000
0.1878%
$3.47$347,000-10.32%
2021-05-14PurchaseVolitionRx Limited
VNRX
director
200,000
0.3644%
$3.29$658,000-7.92%
2018-08-16PurchaseVolitionRx Limited
VNRX
director
100,000
0.3521%
$2.00$199,984+67.63%
2015-02-11PurchaseVolitionRx Limited
VNRX
director
100,000
0.5597%
$3.75$375,000-2.21%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.